News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Diego Díaz García: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials
Diego A. Díaz García/X
Jun 22, 2025, 11:09

Diego Díaz García: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials

Diego Díaz García, Medical Oncologist, CEO and Founder of CánCare, posted on X:

“Are we overestimating success in ph3 oncology trials?
Only 6% of ph3 oncology RCTs show improvement in both OS and QoL.
Most “positive” trials rely on surrogate endpoints, often without adjusting QoL for baseline. We must refocus trials on what truly matters to patients.”

Title: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials

Authors: Alexander D. Sherry, Avital M. Miller, Jnana Preeti Parlapalli, Gabrielle S. Kupferman, Esther J. Beck, Jordan McDonald, Ramez Kouzy, Joseph Abi Jaoude, Timothy A. Lin, Nina N. Sanford, Fumiko Chino, Bishal Gyawali, Christopher Booth, Pavlos Msaouel, Ethan B. Ludmir

Read The Full Article at JAMA Oncology.

Diego Díaz García: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials

More posts featuring Diego Díaz García.

Alexander D. Sherry Avital M Miller Bishal Gyawali cancer Christopher Booth Diego Díaz García Esther J Beck Ethan B Ludmir Fumiko Chino Gabrielle S Kupferman Jnana Preeti Parlapalli Jordan McDonald Joseph Abi Jaoude Nina N. Sanford OncoDaily Oncology Pavlos Msaouel Ramez Kouzy Timothy A Lin
Special Coverage
Blog
Jun 22, 2025, 11:09
Diego Díaz García: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials
Blog
Jun 22, 2025, 11:00
Massimo Di Maio Reflects on AIOM Conference Discussion on Clinical Guidelines and RWD
Insight
Jun 22, 2025, 10:42
Michael Chuong Highlighted Phase 3 PANOVA-3 Trial on TTFields in Locally Advanced Pancreatic Cancer
Insight
Jun 22, 2025, 10:40
Union for International Cancer Control Highlighted 2025 Global Cervical Cancer Elimination Forum in Bali
Insight
Jun 22, 2025, 10:39
Orouba Almilaji Shared IDIOM V Study on Falling GI Cancer Prevalence and PPI Use in Iron Deficiency Anaemia Patients
Stories
Jun 22, 2025, 10:37
Children Facing Pediatric Cancer Can Have Their Families and Siblings Nearby - World Child Cancer USA
Blog
Jun 22, 2025, 10:35
Jarushka Naidoo Shares Duncan Preece’s Patient-Focused Insights from ALK Positive Canada
Insight
Jun 22, 2025, 10:35
Yan Leyfman Highlighted Science Study on In Vivo CAR-T Cell Generation for Cancer and Autoimmune Disease
Insight
Jun 22, 2025, 10:34
Arif Kamal: Cancer Doesn’t Wait - Neither Can We
Insight
Jun 22, 2025, 10:33
Michael Chuong: Excited That the Phase 3 NRG ONCOLOGY GI011 Trial in Locally Advanced Pancreatic Cancer Has Been Activated
Blog
Jun 22, 2025, 10:24
Aadel Chaudhuri Shares Strong R01 Scores in Latest NIH Grant Cycle
Blog
Jun 22, 2025, 10:23
Amol Akhade: WhatsApp-Based Global Oncology Academic Group Launched for Collaborative Learning